EC 35 (Atelvia risedronate sodium delayed-release 35 mg)

Generic Name: risedronate

Pill imprint EC 35 has been identified as Atelvia risedronate sodium delayed-release 35 mg.

Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Atelvia

Generic Name:

risedronate

Imprint:

EC 35

Strength:

risedronate sodium delayed-release 35 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Warner Chilcott Laboratories

National Drug Code (NDC):

00430-0979

Inactive Ingredients:

edetate disodium
ferric oxide yellow
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polysorbate 80
microcrystalline cellulose
dimethicone
sodium starch glycolate type A potato
stearic acid
magnesium silicate
triethyl citrate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00591-3876	Watson Pharmaceuticals, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.